John Nuss, Chief Scientific Officer at Ventyx Biosciences, Inc. (VTYX), sold 19,277 shares at $29.94 ($578K) on 2023-10-03, disclosed to the SEC on 2023-10-04.
Open-market sale of $578k VTYX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.94 | 9,277 | $278K | 48.1% |
| 2 | $29.94 | 9,277 | $278K | 48.1% |
| 3 | $30.72 | 723 | $22K | 3.8% |
| Total | $29.97 avg | 19,277 | $578K | 100% |
| Filing → |
| VTYX | SELL | 2024-12-30 | $50K | — | Filing → |
| VTYX | SELL | 2024-12-19 | $30K | — | Filing → |
| VTYX | SELL | 2024-04-03 | $9K | — | Filing → |